Levels of vascular endothelial growth factor in patients with rheumatoid arthritis

Author： Ardicoglu Ozge   Boz Kenan   Kamanli Ayhan   Kavuncu Vural   Canatan Halit   Onal Suleyman   Ozgocmen Salih  

Publisher： Maney Publishing

ISSN： 1568-5691

Source： The Pain Clinic, Vol.16, Iss.2, 2004-06, pp. : 187-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients

By Tarnowski B.  

Breast Cancer Research and Treatment, Vol. 88, Iss. 3, 2004-12 ,pp. : 287-288

Springer Publishing Company

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor (VEGF) Serum Levels Are Associated With Survival in Early Stages of Lung Cancer Patients

By Pau Enrique Carrillo-de Santa   Arias Fernando Carrillo   Pelaez Enrique Caso   Trueba Ignacio Muguruza   Hernández Ignacio Sánchez   Molina Gemma María Muñoz   Balsalobre Ramón Moreno   López Silvia Sacristán   Gómez-Pinillos Alejandro   Toledo Lobo Maria del Val  

Cancer Investigation, Vol. 28, Iss. 4, 2010-04 ,pp. : 393-398

Informa Healthcare

Access to resources Recommend Favorite

Serum levels of vascular endothelial growth factor are increased and correlate with malnutrition, immunosuppression involving MDSCs and systemic inflammation in patients with cancer of the digestive system

By                          

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1682-1686

Spandidos Publications

Access to resources Recommend Favorite

High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma

By Rueda Antonio   Rifá Julio   Quero Cristina   Gómez-Codina José   Murias Adolfo   García-Arroyo Francisco Ramón   Sabín Pilar   Llanos Marta   Herrero Joaquin   Lobo Francisco   Delgado Juan Ramón   Provencio Mariano    

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1413-1416

Informa Healthcare

Access to resources Recommend Favorite

Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma

By Manenti L.   Paganoni P.   Floriani I.   Landoni F.   Torri V.   Buda A.   Taraboletti G.   Labianca R.   Belotti D.   Giavazzi R.  

European Journal of Cancer, Vol. 39, Iss. 13, 2003-09 ,pp. : 1948-1956

Elsevier

Access to resources Recommend Favorite